On June 14, Pacific Healthcare, a subsidiary of CPIC, successfully held the "Guangqi Health, Key to Building a New Life" Cell Health Forum in Nanjing. Shanghai Cell Therapy Group, Zhongyuan Jisheng, Xinchao Biotech, Jiangsu Saigu and other leading companies in the cell field, as well as relevant persons in charge and experts of China Taibao Life Insurance attended the event. The service brand of "Cell Light Key Project" was released simultaneously.
Cell experts talked about accelerating the high-quality development of the cell industry
The human body is made up of hundreds of millions of cells, which carry various functions including immune defense, metabolism, energy production, and more. Keeping cells healthy can not only improve the body's resistance and reduce the occurrence of diseases, but also affect the aging process to a certain extent. With the continuous upgrading of people's health awareness, the attention to cellular health is also increasing.
In this context, this forum specially invited Professor Gao Quanli, Director of the Department of Immunotherapy, Henan Cancer Hospital, a senior expert in the field of cell research and tertiary hospitals, Professor Shi Ming, Executive Director of the National and Local Joint Engineering Laboratory for Tumor Biotherapy, Professor Chen Fang of the Department of Biochemistry and Molecular Biology of the School of Basic Medical Sciences of Nanjing Medical University, and Professor Gu Jian of the First Affiliated Hospital of Nanjing Medical University to focus on the latest progress of global cell therapy technology and carry out in-depth extension around the hot topics that customers are concerned about. Explore the upgrade model of cellular health services.
Professor Gao Quanli expounded on the application of immune cells in tumor treatment with the title of "Immune Cell Therapy for Malignant Tumors". He popularized the immune process of chemoradiotherapy against tumors and the principle of immunity. He then introduced tumor-infiltrating lymphocyte (TIL) therapy technology, CAR-T cell technology, and several emerging immune cell therapies (such as TCR-T cells and CAR-NK cells), and finally emphasized that "the development of immune cell therapy in cancer treatment is very promising, and it will also benefit patients." ”
Focusing on the theme of "Bispecific CAR-T Development and Clinical Translation", Professor Shi Ming shared the development of dual-targeting CD19+ BCMA CAR-T cells, a cutting-edge technology for cell therapy. This biproperty CAR-T cell has a good safety profile and excellent efficacy. Clinical data showed that 92% of patients had remission and 62% had complete remission, with mild side effects. This provides a new treatment option for patients with relapsed and refractory advanced multiple myeloma. In addition, this bispecific CAR-T therapy has shown promising results in autoimmune diseases such as chronic Guillain-Barré syndrome, myasthenia gravis, and systemic lupus erythematosus. In the future, we will continue to promote the research and development of CAR-T cell therapy drugs and jointly promote the development of this field.
Professor Gu Jian, with the title of "Research on the Transformation of Regulatory T Cells", introduced that Treg cells maintain immune self-tolerance and homeostasis by inhibiting abnormal or excessive immune responses. At present, there are more than 1,200 Treg-related clinical research registrations worldwide, covering transplant-versus-host diseases, autoimmune diseases, etc. The research team has developed a mature Treg cell expansion technology to solve the problems of expansion difficulty and stability, and has shown its effectiveness in the treatment of immune tolerance and autoimmune diseases after liver transplantation in clinical trials, which has been demonstrated on many top platforms at home and abroad and has been widely recognized. The application of Treg in diseases such as organ transplantation and autoimmune diseases is promising.
Professor Chen Fang gave a speech on the topic of "What are the "multi-functional" stem cells - the function and application of stem cells", she pointed out that stem cells are the fundamental guarantee of human health, which can differentiate into various types of cells to ensure the normal operation of the body. Clinical studies and treatment cases at home and abroad have shown that stem cells can be a one-stop solution to the diseases of eight major systems of the human body, including the endocrine system, respiratory system, cardiovascular system, and digestive system. In terms of therapeutic advantages, stem cell therapy has high safety and efficacy, and its allogeneic application is not affected by the patient's own body conditions, and in some specific cases, it can even cure diseases that cannot be treated by conventional means, bringing hope for some patients with immune diseases. In recent years, stem cells have also proven their special role in anti-aging, such as repairing damaged cells from the source, improving cell metabolism, and activating senescent cells. Not only that, the anti-aging effect of stem cells can be said to be applicable to almost all people, and its future development is full of imagination.
Professor Qian Qijun, President of the Shanghai Institute of Cell Therapy and winner of the National Science Fund for Distinguished Young Scholars, said: People are living longer and longer, but many elderly people suffer from three to four chronic diseases. Through cell therapy, people can age healthily and longevity can become a well-being for human beings. One of the directions of scientists' efforts is to continuously reduce the cost of cell therapy, so that more and more people can live a healthy and long life, which is a positive contribution to the silver economy.
Reconstruct the service elements and upgrade and release the service brand of "Cell Light Key Project".
Pacific Medical Health officially launched the cell health project in September 2019, and after nearly five years of deep cultivation and layout, it has now built a one-stop cell health service platform, covering more than 40 key cities across the country, forming an ecological closed loop of "multi-point storage, multi-point sampling, and multi-point service", providing customers with a full range of cell health management services.
In addition to the product system, the service brand of "Cell Light Key Project" has reconstructed and upgraded the original cell health service elements, forming a new product system that includes immune cell storage, customized cell management and cell derivatives.
The release of the "Cell Light Key Program" service brand is another important starting point for Pacific Medical and Health to further enrich the big health ecosystem of CPIC Life Insurance, and also marks a further step in the company's operation and management in the field of cell health, and its application and development prospects in the insurance industry are promising.
The relevant person in charge of Pacific Medical and Health said: "As an innovative health management project for mid-to-high-end life insurance customers, Cell Health Service has received great attention and welcome from customers and marketing teams, and has reached nearly 300,000 middle and high school customers and served more than 70,000 customers. The deep integration of insurance and cell health management services will help give full play to their respective advantages, realize complementary resources, serve the national strategy, promote the development of the industry, improve people's livelihood and well-being, and help a healthy future. ”
In the future, Pacific Medical and Health will continue to uphold the values of "caring, professionalism, innovation, and harmony", with the mission of "health services accessible to everyone, and a better life shared by all families", in the field of health management, starting from the development trend of the industry, accurately grasp the diverse needs of customers, and provide one-stop solutions of "prevention, diagnosis, treatment, and recovery" to meet the medical and health needs of customers throughout the life cycle.